Lv11
90 积分 2025-10-16 加入
Kinetic rate calculation via non-equilibrium dynamics
7小时前
已完结
Understanding drug-target residence time and the implications on drug discovery
9小时前
已完结
Improving individual committor estimates and data efficiency in reaction coordinate tests with the empirical Bayes method
1个月前
已关闭
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
7个月前
已完结
Safety, Pharmacokinetics, and Efficacy of TY-9591 (Deuterated Osimertinib Derivative) in Advanced EGFR-mutated Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation and Dose-Expansion Study
8个月前
已完结
Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study
9个月前
已完结
皖公网安备34019202002308
